MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
41.34
-0.44
-1.05%
Closed 18:20 07/08 EDT
OPEN
41.52
PREV CLOSE
41.78
HIGH
42.13
LOW
41.22
VOLUME
1.75M
TURNOVER
25.10M
52 WEEK HIGH
52.34
52 WEEK LOW
23.95
MARKET CAP
6.58B
P/E (TTM)
-13.8455
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IONS last week (0630-0704)?
Weekly Report · 2d ago
Should You Buy Ionis Pharmaceuticals (IONS) After Golden Cross?
NASDAQ · 6d ago
Ionis Pharmaceuticals (IONS) Moves 9.1% Higher: Will This Strength Last?
NASDAQ · 6d ago
Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Shares Climb 28% But Its Business Is Yet to Catch Up
Simply Wall St · 6d ago
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Benzinga · 07/01 16:44
Nike upgraded, Sportradar initiated: Wall Street’s top analyst calls
TipRanks · 07/01 13:36
Ionis Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays
Dow Jones · 07/01 12:06
Ionis Pharmaceuticals Price Target Raised to $57.00/Share From $51.00 by Barclays
Dow Jones · 07/01 12:06
More
About IONS
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.